10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106,838 | +44.1% | 1,915 | -5.9% | 0.00% | – |
| Q4 2022 | $74,155 | -96.3% | 2,035 | -92.3% | 0.00% | -100.0% |
| Q1 2022 | $2,019,000 | -74.2% | 26,537 | -49.5% | 0.01% | -74.1% |
| Q4 2021 | $7,828,000 | +29.9% | 52,550 | +27.0% | 0.03% | +28.6% |
| Q3 2021 | $6,026,000 | -27.9% | 41,392 | -10.3% | 0.02% | -22.2% |
| Q1 2021 | $8,354,000 | -51.2% | 46,152 | -61.9% | 0.03% | -56.5% |
| Q4 2020 | $17,134,000 | – | 121,006 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |